A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 3,234 shares of REGN stock, worth $2.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,234
Previous 3,323 2.68%
Holding current value
$2.31 Million
Previous $3.49 Million 2.66%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $91,144 - $106,956
-89 Reduced 2.68%
3,234 $3.4 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $675,648 - $819,460
765 Added 29.91%
3,323 $3.49 Million
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $2.31 Million - $2.54 Million
2,558 New
2,558 $2.34 Billion
Q4 2023

Aug 14, 2024

BUY
$775.18 - $881.7 $120,152 - $136,663
155 Added 12.05%
1,441 $1.27 Billion
Q3 2023

Aug 14, 2024

SELL
$692.45 - $844.37 $186,961 - $227,979
-270 Reduced 17.35%
1,286 $1.06 Billion
Q2 2023

Aug 14, 2024

SELL
$700.03 - $830.35 $1.35 Million - $1.61 Million
-1,934 Reduced 55.42%
1,556 $1.12 Billion
Q1 2023

Aug 14, 2024

BUY
$680.49 - $826.97 $538,267 - $654,133
791 Added 29.31%
3,490 $2.87 Billion
Q3 2022

Aug 14, 2024

SELL
$573.97 - $724.32 $3,443 - $4,345
-6 Reduced 0.22%
2,699 $1.86 Billion
Q2 2022

Aug 14, 2024

BUY
$548.35 - $738.84 $846,652 - $1.14 Million
1,544 Added 132.99%
2,705 $1.6 Billion
Q1 2022

Aug 14, 2024

SELL
$595.12 - $698.43 $1.29 Million - $1.51 Million
-2,162 Reduced 65.06%
1,161 $811 Million
Q4 2021

Aug 30, 2024

BUY
$543.48 - $670.97 $80,435 - $99,303
148 Added 21.73%
829 $523 Million
Q3 2021

Aug 30, 2024

SELL
$574.03 - $680.96 $152,117 - $180,454
-265 Reduced 28.01%
681 $412 Million
Q2 2021

Aug 30, 2024

SELL
$472.8 - $558.54 $1.12 Million - $1.33 Million
-2,377 Reduced 71.53%
946 $528 Million
Q1 2021

Aug 30, 2024

SELL
$446.73 - $548.2 $2.22 Million - $2.73 Million
-4,974 Reduced 73.17%
1,824 $863 Million
Q4 2020

Aug 30, 2024

BUY
$478.3 - $607.98 $2.84 Million - $3.61 Million
5,940 Added 692.31%
6,798 $3.29 Billion
Q3 2020

Aug 30, 2024

BUY
$544.75 - $658.21 $94,786 - $114,528
174 Added 25.44%
858 $480 Million
Q2 2020

Aug 30, 2024

BUY
$493.32 - $643.92 $303,885 - $396,654
616 Added 905.88%
684 $427 Million
Q1 2020

Aug 30, 2024

BUY
$336.18 - $494.43 $8,404 - $12,360
25 Added 58.14%
68 $33.2 Million
Q2 2019

Aug 30, 2024

SELL
$299.6 - $414.82 $18,575 - $25,718
-62 Reduced 59.05%
43 $13.5 Million
Q1 2019

Aug 30, 2024

SELL
$372.08 - $439.57 $26,417 - $31,209
-71 Reduced 40.34%
105 $43.1 Million
Q4 2018

Aug 30, 2024

SELL
$335.82 - $403.04 $1.06 Million - $1.27 Million
-3,147 Reduced 94.7%
176 $65.8 Million
Q3 2018

Aug 30, 2024

SELL
$351.14 - $408.51 $5,969 - $6,944
-17 Reduced 8.81%
176 $71.2 Million
Q2 2018

Aug 30, 2024

BUY
$284.6 - $344.99 $42,690 - $51,748
150 Added 348.84%
193 $66.6 Million
Q1 2018

Aug 30, 2024

BUY
$315.82 - $393.78 $13,580 - $16,932
43 New
43 $14.8 Million
Q4 2017

Aug 30, 2024

SELL
$358.63 - $469.95 $10,758 - $14,098
-30 Closed
0 $0
Q2 2017

Aug 30, 2024

SELL
N/A
-208 Reduced 87.39%
30 $14.7 Million
Q1 2017

Aug 30, 2024

SELL
N/A
-3,085
238 $92.2 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.